Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gong Li

Showing results (331-340 of 336) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 336 results.
Liver Cancer|January 2, 2023
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)Yu Yang, Juxian Sun, Mengchao Wu, et al.
Liver Cancer|June 23, 2025
Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition)Yu Yang, Juxian Sun, Jianqiang Cai, et al.
Hepatobiliary Surgery and Nutrition|April 25, 2022
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)Hui-Chuan Sun, Jian Zhou, Zheng Wang, et al.
Natural Product Reports|November 21, 2012
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclaturePaul G Arnison, Mervyn J Bibb, Gabriele Bierbaum, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition)Zheng Wang, Huichuan Sun, Jian Zhou, et al.
Bioscience Trends|December 25, 2024
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)Haowen Tang, Wenwen Zhang, Junning Cao, et al.
Pageof 34

Showing results (331-340 of 336) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 336 results.
Liver Cancer|January 2, 2023
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)Yu Yang, Juxian Sun, Mengchao Wu, et al.
Liver Cancer|June 23, 2025
Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition)Yu Yang, Juxian Sun, Jianqiang Cai, et al.
Hepatobiliary Surgery and Nutrition|April 25, 2022
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)Hui-Chuan Sun, Jian Zhou, Zheng Wang, et al.
Natural Product Reports|November 21, 2012
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclaturePaul G Arnison, Mervyn J Bibb, Gabriele Bierbaum, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition)Zheng Wang, Huichuan Sun, Jian Zhou, et al.
Bioscience Trends|December 25, 2024
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)Haowen Tang, Wenwen Zhang, Junning Cao, et al.
Pageof 34